XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Loss Before Income Taxes

The domestic and foreign components of loss before income taxes from operations for the years ended December 31, 2018 and 2017 are as follows:

 

    For the Years Ended December 31  
    2018     2017  
Domestic     (7,954,841 )     (13,395,048 )
Foreign     (198,214 )     (122,768 )
      (8,153,055 )     (13,517,816 )

Summary of Income Tax Provision (Benefit)

The income tax provision (benefit) consists of the following:

 

 

    Year ended December 31  
    2018     2017  
Federal:                
Current   $ -     $ -  
Deferred     (1,385,438 )     13,026,739  
                 
State and local:                
Current     -       -  
Deferred     (338,773 )     1,724,127  
      (1,724,211 )     14,750,866  
Change in valuation allowance     1,724,211       (14,750,866 )
Income tax provision (benefit)   $ -     $ -  

Schedule of Statutory Federal Income Tax Rate and Effective Tax Rate

The reconciliations between the statutory federal income tax rate and the Company’s effective tax rate is as follows:

 

    Year Ended December 31  
    2018     2017  
             
Tax benefit at federal statutory rate     (21.0 )%     (34.0 )%
State income taxes, net of federal benefit     (5.1 )%     (4.5 )%
Permanent differences     (1.7 )%     (1.9 )%
Effect of change in federal income tax rates on deferred taxes     0.0 %     147.4 %
Change in valuation allowance     20.8 %     (109.0 )%
Prior year true-up     5.8 %     0.0 %
Miscellaneous     1.3 %     2.0 %
Effective income tax rate     0.0 %     0.0 %

Schedule of Components of Deferred Income Taxes

The components of the Company’s deferred income taxes are summarized below:

 

    December 31  
    2018     2017  
Deferred Tax Assets:                
Net operating loss carryforwards   $ 41,114,624     $ 40,156,864  
Stock-based compensation     2,207,465       2,207,465  
Research and development credit carryovers     2,791,710       2,591,539  
Contribution carryovers     10,062       10,715  
Accrued liabilities     490,467       -  
Gross deferred tax assets     46,614,328       44,966,584  
                 
Deferred Tax Liabilities:                
Intangible assets     (235,013 )     (410,410 )
Prepaid expenses     (90,881 )     -  
Other     (29,545 )     (21,496 )
Gross deferred tax liabilities     (355,439 )     (431,906 )
                 
Valuation allowance     (46,258,889 )     (44,534,678 )
                 
Deferred tax asset, net of valuation allowance   $ -     $ -  
                 
Change in valuation allowance   $ (1,724,211 )   $ 14,750,866